Published in Immunology on April 01, 2005
Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer Res (2008) 1.63
Th17 cell accumulation is decreased during chronic experimental colitis by (n-3) PUFA in Fat-1 mice. J Nutr (2011) 1.08
In vivo imaging of mucosal CD4+ T cells using single photon emission computed tomography in a murine model of colitis. J Immunol Methods (2007) 0.97
Chronic colitis induces expression of β-defensins in murine intestinal epithelial cells. Clin Exp Immunol (2010) 0.88
Multifunctional activity of a small tellurium redox immunomodulator compound, AS101, on dextran sodium sulfate-induced murine colitis. J Biol Chem (2014) 0.79
Dietary α-mangostin, a xanthone from mangosteen fruit, exacerbates experimental colitis and promotes dysbiosis in mice. Mol Nutr Food Res (2014) 0.78
Induction and cellular expression of tartrate resistant acid phosphatase during dextran sodium sulphate induced colitis in rats. Histochem Cell Biol (2009) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med (1998) 19.03
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell (1993) 11.95
A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology (1990) 11.22
Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest (1993) 10.09
Interleukin-2: inception, impact, and implications. Science (1988) 8.19
Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol (1998) 5.77
Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature (1991) 5.51
CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity (2002) 5.38
Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science (1991) 5.12
Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology (1994) 4.57
Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol (1998) 3.56
Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol (2002) 3.35
Immune responses in interleukin-2-deficient mice. Science (1993) 3.29
IL-2, regulatory T cells, and tolerance. J Immunol (2004) 3.13
Activation requirements for the induction of CD4+CD25+ T cell suppressor function. Eur J Immunol (2004) 2.99
Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol (1995) 2.90
Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol (1998) 2.76
Inhibition of human CD4(+)CD25(+high) regulatory T cell function. J Immunol (2002) 2.61
Monoallelic expression of the interleukin-2 locus. Science (1998) 2.58
Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion (2000) 2.09
IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am J Physiol (1999) 1.83
Interleukin 2 and its receptors: recent advances and new immunological functions. Immunol Today (1996) 1.81
Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TcR-gammadelta expression. Gut (2000) 1.60
Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance. Immunol Rev (1995) 1.58
Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice. J Immunol (1998) 1.57
Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms. Eur J Immunol (2001) 1.55
Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis. Eur J Immunol (1995) 1.47
Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol (1997) 1.40
Role of gamma delta T cells in the inflammatory response of experimental colitis mice. J Immunol (2003) 1.39
Regional specialization of the mucosal immune system. Intraepithelial lymphocytes of the large intestine have a different phenotype and function than those of the small intestine. J Immunol (1993) 1.39
The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur J Gastroenterol Hepatol (2000) 1.33
Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin Exp Immunol (2003) 1.31
CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice. Eur J Immunol (2002) 1.30
Intra-epithelial lymphocytes. Evidence for regional specialization and extrathymic T cell maturation in the human gut epithelium. Int Immunol (1995) 1.19
T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice. J Exp Med (1995) 1.14
Mechanisms of diarrhea in the interleukin-2-deficient mouse model of colonic inflammation. Am J Physiol Gastrointest Liver Physiol (2004) 1.12
CD4+ CD25+ Treg: divide and rule? Immunology (2004) 1.11
Involvement of CD4+ T cells in the development of dextran sulfate sodium-induced experimental colitis and suppressive effect of IgG on their action. Gen Pharmacol (1998) 1.09
Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease. Gastroenterology (1991) 1.07
The inflammatory infiltrate in the acute stage of the dextran sulphate sodium induced colitis: B cell response differs depending on the percentage of DSS used to induce it. BMC Clin Pathol (2001) 1.01
Participation of the CD69 antigen in the T-cell activation process of patients with systemic lupus erythematosus. Scand J Immunol (1998) 0.92
Allelic selection of human IL-2 gene. Eur J Immunol (2000) 0.86
Neuroendocrine changes in colon of mice with a disrupted IL-2 gene. Clin Exp Immunol (2000) 0.84
Both substance P and its receptor are expressed in mouse intestinal T lymphocytes. Neuroendocrinology (2001) 0.83
Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology (2005) 5.92
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol (2002) 3.72
Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am J Gastroenterol (2004) 2.25
Paradoxical coexpression of proinflammatory and down-regulatory cytokines in intestinal T cells in childhood celiac disease. Gastroenterology (2002) 2.11
A Vibrio cholerae protease needed for killing of Caenorhabditis elegans has a role in protection from natural predator grazing. Proc Natl Acad Sci U S A (2006) 1.78
High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology (2005) 1.45
[Lhx2 seems to inhibit the development of liver cirrhosis. Gene discovery makes the development of drugs against this enormous health problem possible]. Lakartidningen (2006) 1.39
Proximal small intestinal microbiota and identification of rod-shaped bacteria associated with childhood celiac disease. Am J Gastroenterol (2009) 1.26
Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol (2008) 1.19
Probiotics during weaning reduce the incidence of eczema. Pediatr Allergy Immunol (2009) 1.10
Intestinal T-cell responses in celiac disease - impact of celiac disease associated bacteria. PLoS One (2013) 1.07
Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion (2008) 1.05
Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience. Liver Int (2008) 1.00
High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis. Eur J Intern Med (2008) 0.98
Concomitant increase of IL-10 and pro-inflammatory cytokines in intraepithelial lymphocyte subsets in celiac disease. Int Immunol (2007) 0.97
Early infections are associated with increased risk for celiac disease: an incident case-referent study. BMC Pediatr (2012) 0.96
Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand J Gastroenterol (2008) 0.94
Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis. J Med Chem (2014) 0.91
Beta-defensin production by human colonic plasma cells: a new look at plasma cells in ulcerative colitis. Inflamm Bowel Dis (2007) 0.90
Gastrointestinal symptoms are associated with hypothalamic-pituitary-adrenal axis suppression in healthy individuals. Scand J Gastroenterol (2007) 0.88
Vibrio cholerae cytolysin causes an inflammatory response in human intestinal epithelial cells that is modulated by the PrtV protease. PLoS One (2009) 0.87
Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response. Scand J Gastroenterol (2010) 0.87
Peptide YY in gastrointestinal disorders. Peptides (2002) 0.86
Antimicrobial peptides in the duodenum at the acute and convalescent stages in patients with diarrhea due to Vibrio cholerae O1 or enterotoxigenic Escherichia coli infection. Microbes Infect (2011) 0.85
Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer. Int J Cancer (2011) 0.84
Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Eur J Clin Pharmacol (2011) 0.83
Human small intestinal mucosa harbours a small population of cytolytically active CD8+ alphabeta T lymphocytes. Immunology (2002) 0.83
CD4(+) T lymphocytes mediate colitis in HLA-B27 transgenic rats monoassociated with nonpathogenic Bacteroides vulgatus. Inflamm Bowel Dis (2007) 0.82
Steroid receptor expression in vaginal epithelium of healthy fertile women and influences of hormonal contraceptive usage. Contraception (2005) 0.82
Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients. J Hepatol (2008) 0.81
Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population. Scand J Gastroenterol (2011) 0.80
Autoimmune hepatitis among fertile women: strategies during pregnancy and breastfeeding? Scand J Gastroenterol (2007) 0.80
Prevotella jejuni sp. nov., isolated from the small intestine of a child with coeliac disease. Int J Syst Evol Microbiol (2013) 0.79
Meta-analysis of the effectiveness and safety of prophylactic use of nimodipine in patients with an aneurysmal subarachnoid haemorrhage. CNS Neurol Disord Drug Targets (2011) 0.79
Transitions between variant forms of primary biliary cirrhosis during long-term follow-up. Eur J Intern Med (2009) 0.79
Early vaccinations are not risk factors for celiac disease. Pediatrics (2012) 0.79
Formula feeding skews immune cell composition toward adaptive immunity compared to breastfeeding. J Immunol (2009) 0.78
Incidence of Augmentation in Primary Restless Legs Syndrome Patients May Not Be That High: Evidence From A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2016) 0.75
[Acute liver failure--rapid multidisciplinary management]. Lakartidningen (2007) 0.75
Peter Perlmann 1919-2005. Scand J Immunol (2006) 0.75
[Autoimmune hepatitis often requires lifelong treatment]. Lakartidningen (2010) 0.75
[Liver diseases in focus for Swedish research]. Lakartidningen (2010) 0.75
[Guidelines for management of patients with chronic pancreatitis. Report from a consensus conference]. Lakartidningen (2003) 0.75
Celiac disease: effect of weaning on disease risk. Nestle Nutr Workshop Ser Pediatr Program (2005) 0.75